Data complete?
Evaluation appropriate?
Body surface area (Dubois & Dubois formula)
Dose of the known anthracycline
Does this exceed the threshold for 5% cardiotoxicity?
Dose as percent of the dose associated with 5% cardiotoxicity
Equivalent dose of daunorubicin from a cardiotoxicity perspective
Caution: A qualified health practitioner should verify all results.Keep patient data confidential and comply with all legal requirements.
Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited
Purpose: To evaluate a patient being treated with an anthracycline.
Specialty: Hematology Oncology, Cardiology
Objective: adverse effects
ICD-10: T45.1,
